Navigation Links
TGen, Virginia G. Piper Cancer Center scientist heads lung cancer consortium

SCOTTSDALE, Ariz. June 8, 2011 Dr. Glen Weiss, who holds joint appointments at the Translational Genomics Research Institute (TGen) and at the Virginia G. Piper Cancer Center at Scottsdale Healthcare, is the new Chief Medical Officer of an international lung cancer research consortium.

In this new position, Dr. Weiss heads the Cancer Research and Biostatistics-Clinical Trials Consortium (CRAB-CTC), a Seattle-based cooperative research network, created by a group of preeminent lung cancer investigators. It represents more than 10 institutes worldwide dedicated to funding and facilitating clinical trials, thereby providing lung cancer patients with newly developed therapeutics as quickly as possible.

"Our Consortium's explicit mission is to organize and accelerate the clinical development of new agents for the treatment of patients with lung cancer," said Dr. Weiss, an Assistant Professor of TGen's Cancer and Cell Biology Division. He also is Director of Thoracic Oncology at Virginia G. Piper Cancer Center Clinical Trials, a partnership between TGen and Scottsdale Healthcare that treats cancer patients with promising new drugs through clinical trials at the Virginia G. Piper Cancer Center in Scottsdale, Ariz.

CRAB-CTC members include laboratory and clinical researchers in the U.S., Canada and China who share a passion for bringing new scientific advances to patients with lung cancer as rapidly as possible.

"Our Consortium provides a well-coordinated effort dedicated to rapidly translating research discoveries into new treatments and supportive care for patients with lung cancer," said Dr. Weiss.

Unlike similar research consortiums, CRAB-CTC is not affiliated or funded by government, but works directly with pharmaceutical firms to advance their compounds.

"CRAB's mission is to help conquer cancer. The network provided by the CRAB-CTC enables research oncologists to design and conduct innovative studies more quickly, in more places and with greater degree of opportunity for specific patient needs," said Dr. John Crowley, CEO of CRAB and lead statistician for multiple cancer clinical trials.

"What this will mean for patients, is that we will be able to offer patients new therapies much faster," Dr. Weiss said.


Contact: Steve Yozwiak
The Translational Genomics Research Institute

Related biology news :

1. TGen, Scottsdale Healthcare, Mayo Clinic study new drug to stimulate immune system of cancer victims
2. Virginia Tech mechanical engineers win measurement science best paper award
3. Virginia Tech announces football helmet ratings for reducing concussion risk
4. Young scientist at Virginia Commonwealth University wins Avanti prize
5. Virginia Tech forest researcher awarded NSF early career grant
6. Virginia Tech researcher seeks to use electrical stimulation to give voice to stroke patients
7. Virginia Tech shares in grant to study effects of climate change on southern pine forests
8. Virginia Tech engineer identifies new concerns for antibiotic resistance, pollution
9. Virginia Tech engineers introduce thermotherapy as a chemotherapy alternative
10. USDA awards Virginia Tech $3.8 million to stimulate eastern US wine industry
11. Virginia Tech studies impact of Gulf oil spill on plovers
Post Your Comments:
(Date:6/9/2016)... , June 9, 2016 ... Police deploy Teleste,s video security solution to ensure the safety ... France during the major tournament Teleste, ... communications systems and services, announced today that its video security ... to back up public safety across the country. ...
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of ... their brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been ... Target to its list of well-respected retailers. This list includes such fine stores ...
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology: